Oslo, December 8, 2017
Bionor was purchased by the founder of Bionor AS, Birger Sørensen and his team, on September 28, 2017 with financial closing as of today.
With the assistance of Norse Securities, the new owners/management have successfully raised funds for the purchase and future operations.
Birger Sørensen and his team will immediately start implementing the new strategy focusing on the combined vaccines Vacc-4x and Vacc-C5 towards a functional cure against HIV.